Total Funding
57
12
Total FundingSeries A raised
Growth Score 57 in past quarter
-3 pts
Heat Score 12 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
51677
Stemson Therapeutics is a pre-clinical stage cell therapy company.
- Kevin D’Amour: Chief Scientific OfficerPast Role: ViaCyte, Vice President, Research and CSO
Alexey V. Terskikh: Co-Founder & Chief Scientific OfficerPast Role: Stelvio Therapeutics, CSO
About the Company
Stemson Therapeutics is driven by a vision where anyone battling the emotional trauma or social stigma of hair loss has an opportunity to truly cure their condition and safely restore their natural hair. Our engineered cells are combined with a unique tissue engineering solution and are capable of generating a net new supply of hair follicles for
patients in need. Stemson